BeyondSpring (BYSI) Total Liabilities (2015 - 2026)
BeyondSpring's (BYSI) quarterly Total Liabilities came in at $50.6 million in Q2 2026, up 4.2% year-over-year from $48.6 million in Q2 2025, and up 3.84% quarter-over-quarter from $48.8 million in Q1 2026.
Analysis
BeyondSpring (BYSI) Total Liabilities (2015 - 2026) Analysis & Trends
BeyondSpring has disclosed Total Liabilities across 12 years of filings, most recently posting $50.6 million for Q2 2026.
- In Q2 2026, Total Liabilities rose 4.2% year-over-year to $50.6 million; the TTM figure through Jun 2026 stood at $50.6 million (up 4.2% YoY), while the FY2025 annual figure was $49.9 million, up 2.72% from the prior year.
- Total Liabilities came in at $50.6 million for Q2 2026 at BeyondSpring, up from $48.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $52.0 million in Q2 2022 to a low of $11.0 million in Q3 2024.
- Average Total Liabilities over 5 years is $45.6 million, with a median of $48.7 million recorded in 2024.
- Year-over-year, Total Liabilities dropped 10.93% in 2022 and surged 347.52% in 2025.
- Over 5 years, Total Liabilities stood at $49.2 million in 2022, then dropped by 1.95% to $48.3 million in 2023, then gained by 0.69% to $48.6 million in 2024, then rose by 2.72% to $49.9 million in 2025, then advanced by 1.42% to $50.6 million in 2026.
- Per Business Quant data, the three most recent Total Liabilities figures were $50.6 million in Q2 2026, $48.8 million in Q1 2026, and $49.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 116.09 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 141.05 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 23.74 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 80.09 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 115.64 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 69.15 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 1.72 Bn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 1.53 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 819.80 Mn |
| 10 | BeyondSpring | 31.51 Mn | 31.51 Mn | - | 50.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.63 Mn |
| Mar 31, 2026 | 48.76 Mn |
| Dec 31, 2025 | 49.92 Mn |
| Sep 30, 2025 | 49.29 Mn |
| Jun 30, 2025 | 48.59 Mn |
| Mar 31, 2025 | 49.77 Mn |
| Dec 31, 2024 | 48.60 Mn |
| Sep 30, 2024 | 11.02 Mn |
| Jun 30, 2024 | 47.17 Mn |
| Mar 31, 2024 | 38.17 Mn |
| Dec 31, 2023 | 48.27 Mn |
| Jun 30, 2023 | 47.57 Mn |
| Dec 31, 2022 | 49.23 Mn |
| Jun 30, 2022 | 52.03 Mn |
| Dec 31, 2021 | 55.27 Mn |
| Sep 30, 2021 | 59.21 Mn |
| Jun 30, 2021 | 24.74 Mn |
| Mar 31, 2021 | 21.53 Mn |
| Dec 31, 2020 | 25.22 Mn |
| Sep 30, 2020 | 16.47 Mn |